INSTITUTE FOR RATIONAL PHARMACOTHERAPY (IRF)

The aim of the IRF is to promote the most rational use of current and future medicinal products with respect to both pharmacological and economical aspects. This aim is directed towards both primary and hospital care. 

 

 Read more about IRF

REVIEWS

Intuniv® (guanfacine)

23 August 2016


Incruse® (umeclidinium)

23 August 2016


Entresto (sacubitril, valsartan)

23 August 2016


Acarizax®

23 August 2016


Spiolto Respimat® (tiotropium/olodaterol)

15 April 2016


Saxenda® (liraglutide)

15 April 2016


Colrefuz® (colchicine)

15 April 2016


Levosert®

15 April 2016


Rupafin® (rupatadine)

04 January 2016


Soolantra (ivermectin)

04 January 2016


Latuda (lurasidone)

04 January 2016


Trulicity (dulaglutide)

04 January 2016


Attentin (dexamfetamine)

04 January 2016


Duaklir Genuair (aclidinium/formoterol)

05 May 2015


Vipidia (alogliptin)

05 May 2015


Urizia (6 mg solifenacin/0.4 mg tamsulosin)

05 May 2015


Ultibro Breezhaler (indacaterol/glycopyrronium)

05 May 2015


Striverdi Respimat (olodaterol)

25 March 2015


Spedra (avanafil)

24 March 2015


Relvar Ellipta (fluticasone furoate/vilanterol)

24 March 2015


Priligy (30 mg or 60 mg dapoxetine)

24 March 2015


Moventig (naloxegol)

24 March 2015


Mirvaso (brimonidine)

24 March 2015


Jardiance (empagliflozin)

24 March 2015


Invokana (canagliflozin)

24 March 2015


Anoro (umeclidinium/vilanterol)

18 March 2015


Brintellix (vortioxetine)

18 March 2015


Alea Comp (olmesartan, hydrochlorothiazide and amlodipine)

06 March 2015


Adenuric (febuxostat)

06 March 2015


Adasuve (loxapine)

06 March 2015


Elvanse (lisdexamphetamine dimesylate)

09 October 2013


Dymista (azelastine + fluticasone)

09 October 2013


Constella (linaclotide)

27 June 2013


Cialis (tadalafil)

13 June 2013


Picato (ingenol mebutate)

13 June 2013


Flutiform (fluticasone + formoterol)

13 June 2013


Hydromed (hydrochlorthiazide)

13 June 2013


Revitelle (bilastine)

13 June 2013


Tresiba (insulin degludec)

13 June 2013


When new products that are of general medical interest enter the Danish market or there are special changes made in already marketed products, the Institute for Rational Pharmacotherapy prepares a short description of how the product should be used within a context of the other available therapies.

 

Go to Reviews

Selected webpages

 

From the Danish Medicines Agency and IRF:

 
 
 
 

Page last updated: 19 September 2016 Institut for Rationel Farmakoterapi - Axel Heides Gade 1 - 2300 København S - tlf. +45 44 88 91 21 - E-mail: irf@dkma.dk